Veterinary Medicines

Albiotic intramamarna raztopina za krave v laktaciji

Authorised
  • Neomycin
  • Lincomycin
Download as PDF

Product identification

Medicine name:
Albiotic intramamarna raztopina za krave v laktaciji
Active substance:
  • Neomycin
  • Lincomycin
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Neomycin
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Lincomycin
    330.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Milk
        84
        hour
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RF03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Available in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0188/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/10/2021
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/10/2021
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/10/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."